MedTrace Logo

Remote Monitoring of Chronic Illness Patients With a IHAP Home Wireless Hub and Vitals Measurements

NCT06330714 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2024-03-26

No results posted yet for this study

Summary

This is planned as a feasibility study.

The primary objective is to evaluate a specially designed patient monitoring software Vitalbeat and standard mobile device hub termed Intel Health Application Platform (IHAP) in terms of its reliability, seamless data transmission and early data availability to the physician to improve patient physician interaction.

The second objective is assessing patient response to use of mobile device monitoring and patient self-monitoring skills to transmit vital signs data using the IHAP wireless home hub device

Conditions

  • Chronic Disease of Cardiovascular System

Interventions

OTHER

Symptoms of chronic illness.

The patient is advised to monitor BP and body weight daily in a standardized fashion as described below: * Body weight should be measured in the morning without clothes or shoes after emptying the urinary bladder but before breakfast. * BP should be measured in the morning preferably using the right arm, sitting comfortably in a chair after 5 minutes of rest in the seated position.

Sponsors & Collaborators

  • Intel Corporation

    collaborator INDUSTRY

  • Aventyn, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2018-11-30
Completion
2018-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06330714 on ClinicalTrials.gov